DarioHealth Corp.
DRIONasdaqCIK 1533998HealthcareFiscal year ends Dec 31
Reports and events: 242 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-105495 |
| 2026-08-2116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-099678 |
| 2026-08-1106:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-093645 |
| 2026-07-2217:19 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-085900 |
| 2026-07-1017:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-082715 |
| 2026-05-1306:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059676 |
| 2026-04-1308:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-042362 |
| 2026-03-3017:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-036834 |
| 2026-03-1906:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-031621 |
| 2026-02-0216:32 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-009247 |
| 2026-01-2916:06 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-007974 |
| 2025-12-2216:12 ET | DEF 14A | Proxy statementPeriod 2026-01-29 | 0001104659-25-123724 |
| 2025-11-1306:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-110730 |
| 2025-11-1016:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-109166 |
| 2025-09-2517:18 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-093431 |
| 2025-09-1917:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-091718 |
| 2025-09-1217:24 ET | 8-K | 8.01 Other events | 0001104659-25-089629 |
| 2025-08-2516:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-082513 |
| 2025-08-1206:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011130 |
| 2025-07-2317:08 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-070069 |
| 2025-07-1016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-066982 |
| 2025-05-3017:16 ET | DEF 14A | Proxy statementPeriod 2025-07-23 | 0001104659-25-054861 |
| 2025-05-2916:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-054236 |
| 2025-05-2107:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-25-051292 |
| 2025-05-1406:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-007640 |
| 2025-05-0607:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-044809 |
| 2025-04-2816:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-040182 |
| 2025-04-2117:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-036910 |
| 2025-03-1916:05 ET | 8-K | 3.01 Delisting notice | 0001104659-25-025549 |
| 2025-03-1419:57 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-023589 |
| 2025-03-1016:05 ET | DEF 14A | Proxy statementPeriod 2025-04-28 | 0001104659-25-022150 |
| 2025-03-1006:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-002527 |
| 2025-02-2716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-018230 |
| 2025-01-2216:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-005237 |
| 2025-01-1016:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-002576 |
| 2024-12-1816:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-129777 |
| 2024-12-1816:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-24-129752 |
| 2024-11-0706:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-014735 |
| 2024-10-2416:15 ET | DEF 14A | Proxy statementPeriod 2024-12-18 | 0001104659-24-111163 |
| 2024-09-2016:05 ET | 8-K | 3.01 Delisting notice | 0001104659-24-101690 |
| 2024-09-1316:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-099762 |
| 2024-08-0806:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-011453 |
| 2024-06-2816:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-076313 |
| 2024-06-2516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-074740 |
| 2024-06-0508:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-068526 |
| 2024-05-1506:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001544784-24-000067 |
| 2024-05-0117:24 ET | DEF 14A | Proxy statementPeriod 2024-06-25 | 0001104659-24-055848 |
| 2024-04-2216:50 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001104659-24-050049 |
| 2024-04-1916:11 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-049443 |
| 2024-04-0516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-044299 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.